InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,585.90
(
0.23%
)
US TECH 100
19,940.80
(
0.24%
)
Dow Jones
39,272.44
(
-0.18%
)
Brent Oil
85.41
(
-0.01%
)
Bitcoin
57,258.79
(
0.97%
)
Post# of 252527
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: grandpatb post# 87858

Thursday, 12/24/2009 5:09:47 AM

Thursday, December 24, 2009 5:09:47 AM

Post# of 252527
Pfizer/Athersys - Big pharmaceutical companies and Stem-Cell Therapy

Novo Nordisk is working with Cellartis on stem-cell treatments for diabetes. Johnson & Johnson has invested in Novocell and Tengion, another regenerative medicine company. GlaxoSmithKline is providing $25 million to Harvard’s stem-cell institute. And Novartis and Roche have invested in Cellerix, a Spanish stem-cell company.

The writer neglected to mention the fact that Teva has a large stake in Gamida Cell's StemEx product, currently in phase II/III for treatment of hem-cancer.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up